药物分子的动力学和放大

Pharmaceutical bioprocessing Pub Date : 2021-01-01 DOI:10.37532/2048-9145.2021.9(3).20-21

S. Gavanji

{"title":"药物分子的动力学和放大","authors":"S. Gavanji","doi":"10.37532/2048-9145.2021.9(3).20-21","DOIUrl":null,"url":null,"abstract":"The use of biopharmaceuticals dates from the 19th century and within 5–10 years, up to 50% of all drugs in development will be biopharmaceuticals. In the 1980s, the biopharmaceutical industry experienced significant growth in the production and approval of recombinant proteins such as interferon’s (IFN α, β, and γ) and growth hormones. The production of biopharmaceuticals, known as bioprocess, involves a wide range of techniques.","PeriodicalId":90285,"journal":{"name":"Pharmaceutical bioprocessing","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dynamics and scale-up of thePharmaceutical molecule\",\"authors\":\"S. Gavanji\",\"doi\":\"10.37532/2048-9145.2021.9(3).20-21\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The use of biopharmaceuticals dates from the 19th century and within 5–10 years, up to 50% of all drugs in development will be biopharmaceuticals. In the 1980s, the biopharmaceutical industry experienced significant growth in the production and approval of recombinant proteins such as interferon’s (IFN α, β, and γ) and growth hormones. The production of biopharmaceuticals, known as bioprocess, involves a wide range of techniques.\",\"PeriodicalId\":90285,\"journal\":{\"name\":\"Pharmaceutical bioprocessing\",\"volume\":\"9 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutical bioprocessing\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37532/2048-9145.2021.9(3).20-21\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical bioprocessing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37532/2048-9145.2021.9(3).20-21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

生物制药的使用可追溯到19世纪，在5-10年内，所有正在开发的药物中高达50%将是生物制药。在20世纪80年代，生物制药行业在生产和批准重组蛋白如干扰素(IFN α， β和γ)和生长激素方面经历了显著的增长。生物制药的生产，被称为生物工艺，涉及广泛的技术。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Dynamics and scale-up of thePharmaceutical molecule

The use of biopharmaceuticals dates from the 19th century and within 5–10 years, up to 50% of all drugs in development will be biopharmaceuticals. In the 1980s, the biopharmaceutical industry experienced significant growth in the production and approval of recombinant proteins such as interferon’s (IFN α, β, and γ) and growth hormones. The production of biopharmaceuticals, known as bioprocess, involves a wide range of techniques.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Pharmaceutical bioprocessing

自引率

0.00%

发文量